More tools:Markets·Screener·Research·Chat

iRadimed Corporation (IRMD) Financial Statements

iRadimed Corporation
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG006NM92Y1
XNAS · usd
83.57▼ 0.83 (-0.98%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close84.40
Day's Range83.20 – 86.77
52-Week Range67.84 – 108.43
Volume104.5K
Avg Volume121.8K
Share Statistics
Shares Outstanding
Employees166
ExchangeXNAS
Listed2014-07-16
Share count as of July 31, 2026
Loading Income Statement…
Key questions about iRadimed Corporation (IRMD)
What is iRadimed Corporation's Market Cap?
iRadimed Corporation's Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Enterprise Value?
iRadimed Corporation's Enterprise Value is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Trailing P/E?
iRadimed Corporation's Trailing P/E is 46.4×, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Price / Sales?
iRadimed Corporation's Price / Sales is 12.4×, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's EV / Revenue?
iRadimed Corporation's EV / Revenue is 11.7×, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's EV / EBITDA?
iRadimed Corporation's EV / EBITDA is 35.0×, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Revenue (TTM)?
iRadimed Corporation's Revenue (TTM) is $86.3M, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Net Income (TTM)?
iRadimed Corporation's Net Income (TTM) is $23.1M, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's EBITDA?
iRadimed Corporation's EBITDA is $29.2M, based on as-reported figures from SEC (XBRL) filings.
What is iRadimed Corporation's Diluted EPS (TTM)?
iRadimed Corporation's Diluted EPS (TTM) is 1.80, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+0.3%+12.6%+17.0%+15.7%
Cost of revenue
Gross profit
% of revenue74.1%76.5%75.1%77.8%
Operating expenses:
General and administrative
Sales and marketing
Research and development
Total operating expenses
% of revenue42.8%43.6%43.8%45.6%
Income from operations
% of revenue31.2%32.9%31.3%32.2%
Other income, net
Income before provision for income taxes
Provision for income tax expense
Net income
% of revenue25.5%26.5%28.4%26.3%
Basic (in dollars per share)
Diluted (in dollars per share)